BMJ, doi: 10.1136/bmj.38766.624097.1F, (Published 1 March 2006)

RESEARCH

Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study

Johan Sundström ^1*, Ulf Risérus ², Liisa Byberg ², Björn Zethelius ², Hans Lithell ², Lars Lind ¹

¹ Department of Medical Sciences, Uppsala University Hospital; SE-751 85 Uppsala, Sweden,
² Department of Public Health and Caring Sciences, Uppsala University Hospital

^* Correspondence to: johan.sundstrom{at}medsci.uu.se.

Objectives To find out if the presence of the metabolic syndrome increases the risk of subsequent total and cardiovascular mortality, taking into account established risk factors for cardiovascular disease.

Design Prospective cohort study.

Setting General population.

Participants A community based sample of 2322 men followed since 1970 for a maximum of 32.7 years, investigated at ages 50 and 70.

Main outcome measures The relations of the metabolic syndrome defined by the national cholesterol education programme (NCEP) of the US National Heart, Lung, and Blood Institute or criteria of the World Health Organization (WHO) to subsequent total and cardiovascular mortality.

Results When adding the metabolic syndrome to models with established risk factors for cardiovascular disease (smoking, diabetes, hypertension, and serum cholesterol) at age 50, presence of the metabolic syndrome as defined in the NCEP significantly predicted total and cardiovascular mortality (Cox proportional hazard ratios 1.36, 95% confidence interval 1.17 to 1.58; and 1.59, 1.29 to 1.95, respectively). The metabolic syndrome added prognostic information to that of the established risk factors for cardiovascular disease (likelihood ratio tests, P<0.0001 for both outcomes). Similar results were obtained in a subsample without diabetes or manifest cardiovascular disease.

Conclusions In a large, community based sample of middle aged men, the presence of the metabolic syndrome according to the definition of the NCEP gave long term prognostic information regarding total and cardiovascular mortality if the status of established risk factors for cardiovascular disease was known. If confirmed this may indicate clinical value in diagnosing the metabolic syndrome.

---

(Accepted 2 February 2006)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Management of hirsutism

Olympia Koulouri and Gerard S Conway
BMJ 2009 338: b847. [Extract] [Full Text]

Predictive value of metabolic syndrome is not clear

Richard J Jarrett
BMJ 2006 332: 1036. [Extract] [Full Text]

Presence of metabolic syndrome improves mortality risk prediction
BMJ 2006 332: 0. [Full Text]

This article has been cited by other articles:

• Lee, J. S., Cho, S.-I., Park, H. S. (2009). Metabolic syndrome and cancer-related mortality among Korean men and women. Ann Oncol 0: mdp344v1-mdp344 [Abstract] [Full text]  
• Brackbill, M. L., Sytsma, C. S., Sykes, K. (2009). Perioperative Outcomes of Coronary Artery Bypass Grafting: Effects of Metabolic Syndrome and Patient's Sex. Am J Crit Care 18: 468-473 [Abstract] [Full text]  
• Levy, P., Bonsignore, M. R., Eckel, J. (2009). Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 34: 243-260 [Abstract] [Full text]  
• Karalis, D. G. (2009). Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease. Mayo Clin Proc. 84: 345-352 [Abstract] [Full text]  
• Koulouri, O., Conway, G. S (2009). Management of hirsutism. BMJ 338: b847-b847 [Full text]  
• Worm, S. W., Sabin, C. A., Reiss, P., El-Sadr, W., d'Arminio Monforte, A., Pradier, C., Thiebaut, R., Law, M., Rickenbach, M., De Wit, S., Lundgren, J. D., Friis-Moller, N. (2009). Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals: Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study. Diabetes Care 32: 474-480 [Abstract] [Full text]  
• Akbaraly, T. N., Kivimaki, M., Brunner, E. J., Chandola, T., Marmot, M. G., Singh-Manoux, A., Ferrie, J. E. (2009). Association Between Metabolic Syndrome and Depressive Symptoms in Middle-Aged Adults: Results from the Whitehall II study. Diabetes Care 32: 499-504 [Abstract] [Full text]  
• Qiao, Q., Laatikainen, T., Zethelius, B., Stegmayr, B., Eliasson, M., Jousilahti, P., Tuomilehto, J. (2009). Comparison of Definitions of Metabolic Syndrome in Relation to the Risk of Developing Stroke and Coronary Heart Disease in Finnish and Swedish Cohorts. Stroke 40: 337-343 [Abstract] [Full text]  
• Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., Fernando, D. J, Idris, I. (2009). The clinical impact of identifying metabolic syndrome in patients with diabetes: a cross-sectional study. Diabetes and Vascular Disease Research 6: 21-24 [Abstract]  
• de Kroon, M. L. A., Renders, C. M., Kuipers, E. C. C., van Wouwe, J. P., van Buuren, S., de Jonge, G. A., Hirasing, R. A. (2008). Identifying metabolic syndrome without blood tests in young adults--The Terneuzen Birth Cohort. Eur J Public Health 18: 656-660 [Abstract] [Full text]  
• Sabio, J., Zamora-Pasadas, M, Jimenez-Jaimez, J, Albadalejo, F, Vargas-Hitos, J, Rodriguez del Aguila, M., Hidalgo-Tenorio, C, Gonzalez-Gay, M., Alonso, J. (2008). Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus 17: 849-859 [Abstract]  
• Mozaffarian, D., Kamineni, A., Prineas, R. J., Siscovick, D. S. (2008). Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study. Arch Intern Med 168: 969-978 [Abstract] [Full text]  
• Chandola, T., Britton, A., Brunner, E., Hemingway, H., Malik, M., Kumari, M., Badrick, E., Kivimaki, M., Marmot, M. (2008). Work stress and coronary heart disease: what are the mechanisms?. Eur Heart J 29: 640-648 [Abstract] [Full text]  
• Maalouf, N. M., Cameron, M. A., Moe, O. W., Adams-Huet, B., Sakhaee, K. (2007). Low Urine pH: A Novel Feature of the Metabolic Syndrome. CJASN 2: 883-888 [Abstract] [Full text]  
• Ninomiya, T., Kubo, M., Doi, Y., Yonemoto, K., Tanizaki, Y., Rahman, M., Arima, H., Tsuryuya, K., Iida, M., Kiyohara, Y. (2007). Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study. Stroke 38: 2063-2069 [Abstract] [Full text]  
• Alberti, S. G. (2007). The metabolic syndrome: setting the scene. The pros. Diabetes and Vascular Disease Research 4: S1-S3 [Abstract]  
• Jeppesen, J., Hansen, T. W., Rasmussen, S., Ibsen, H., Torp-Pedersen, C., Madsbad, S. (2007). Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease: A Population-Based Study. J Am Coll Cardiol 49: 2112-2119 [Abstract] [Full text]  
• Shimizu, H., Inoue, K., Mori, M. (2007). The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. J Endocrinol 193: 1-9 [Abstract] [Full text]  
• Grundy, S. M. (2007). Metabolic Syndrome: A Multiplex Cardiovascular Risk Factor. J. Clin. Endocrinol. Metab. 92: 399-404 [Abstract] [Full text]  
• Lorenzo, C., Williams, K., Hunt, K. J., Haffner, S. M. (2007). The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care 30: 8-13 [Abstract] [Full text]  
• Perel, P., Langenberg, C., Ferrie, J., Moser, K., Brunner, E., Marmot, M. (2006). Household Wealth and the Metabolic Syndrome in the Whitehall II Study. Diabetes Care 29: 2694-2700 [Abstract] [Full text]  
• Wiberg, B., Sundstrom, J., Arnlov, J., Terent, A., Vessby, B., Zethelius, B., Lind, L. (2006). Metabolic Risk Factors for Stroke and Transient Ischemic Attacks in Middle-Aged Men: A Community-Based Study With Long-Term Follow-Up. Stroke 37: 2898-2903 [Abstract] [Full text]  
• Ingelsson, E, Arnlov, J, Lind, L, Sundstrom, J (2006). Metabolic syndrome and risk for heart failure in middle-aged men. Heart 92: 1409-1413 [Abstract] [Full text]  
• Sundstrom, J., Vallhagen, E., Riserus, U., Byberg, L., Zethelius, B., Berne, C., Lind, L., Ingelsson, E. (2006). Risk Associated With the Metabolic Syndrome Versus the Sum of Its Individual Components. Diabetes Care 29: 1673-1674 [Full text]  
• Jarrett, R. J (2006). Predictive value of metabolic syndrome is not clear.. BMJ 332: 1036-1036 [Full text]  
• Farmer, A. (2006). Metabolic syndrome and mortality.. BMJ 332: 882-882 [Full text]  

Rapid Responses:

Read all Rapid Responses

The Metabolic Syndrome: a description in evolution

George I. Varughese, et al.
bmj.com, 14 Mar 2006 [Full text]

Metabolic Syndrome

Richard J Jarrett
bmj.com, 18 Apr 2006 [Full text]

The metabolic syndrome vs. main cardiovascular risk factors: Comparing apples and pears

Pascal Bovet, et al.
bmj.com, 24 May 2006 [Full text]

Early warning for use in primary care to inform patients of risk

Rupert A Gude
bmj.com, 5 Jun 2006 [Full text]

Online poll

Find out more >>